skip to Main Content

TGen and Baylor Poised to Create Early Detection Test for Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
A group of the nation’s premier cancer researchers led by the Baylor Scott & White Research Institute (BSWRI) and the Translational Genomics Research Institute (TGen) — has secured a $5.13 million federal grant to develop an early detection system for pancreatic cancer, the nation’s third-leading cause of cancer-related death.
Because it displays no overt symptoms or pain in its early stages, pancreatic cancer often is not diagnosed until it has spread to other organs, especially the liver and the lungs — a point when surgical removal is often no longer an option. This research has the potential to profoundly transform early detection of pancreatic cancer by creating a non-invasive, rapid, accurate and inexpensive blood test.  Read more . . .


Back To Top